US 6693103
1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators
expired A61KA61K31/4704A61K31/517
Quick answer
US patent 6693103 (1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators) held by Ligand Pharmaceuticals Incorporated expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 59
- CPC classes
- A61K, A61K31/4704, A61K31/517, A61K31/536, A61P